| Name: | Dapagliflozin Acetyl Impurity |
| Catalogue No. | VL1650004 |
| CAS No. | 1632287-34-3 |
| Molecular Formula | C23H27ClO7 |
| Molecular Weight | 450.91 |
| Status | In-stock |
| IUPAC Name | ((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate |
| Appearance | White Solid |
| Description | Dapagliflozin Acetyl Impurity (CAS No.: 1632287-34-3) or ((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate is a metabolite of Dapagliflozin. Dapagliflozin is a gliflozin class drug that is evaluated for the treatment of type-2 diabetes. Dapagliflozin goes through rapid metabolism and transforms into various metabolites in humans. |
| References | KARUMANCHI, KISHORE, et al. “Synthesis of Metabolites of Dapagliflozin: An SGLT2 Inhibitor.” Journal of Chemical Sciences, vol. 132, no. 1, Feb. 2020,https://doi.org/10.1007/s12039-020-1747-x. |
